{"mainPropery":{"diseaseId":6100,"diseaseName":"Chronic granulomatous disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6100/chronic-granulomatous-disease","synonyms":["Granulomatous disease, chronic"],"synonyms-with-source":[{"name":"Granulomatous disease, chronic"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"379"},{"identifierType":"UMLS","identifierId":"C0018203"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"},{"diseaseTypeId":21,"diseaseTypeName":"Lung Diseases","source":"Orphanet"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":161,"resourceName":"Immune Deficiency Foundation","abbreviation":"","address1":"110 West Road, Suite 300","address2":"","address3":"","address4":"","address5":"","city":"Towson","state":"MD","zip":"21204","country":"United States","phone":"","tty":"","tollFree":"1-800-296-4433","fax":"+1-410-321-9165","email":"https://www.primaryimmune.org/services/ask-idf/","url":"https://www.primaryimmune.org/","freeText":""},{"resourceID":721,"resourceName":"Chronic Granulomatous Disease Association, Inc.","address1":"c/o Mary Hurley","address2":"2616 Monterey Road","address3":"","address4":"","address5":"","city":"San Marino","state":"CA","zip":"91108","country":"United States","phone":"626-441-4118","tty":"","tollFree":"","fax":"","email":"","url":"http://www.cgdassociation.org/"},{"resourceID":2936,"resourceName":"CGD Society","abbreviation":"","address1":"PO Box 454  ","address2":"","address3":"","address4":"","address5":"","city":"Dartford","state":"","zip":"DA1 9PE","country":"United Kingdom","phone":"0800 987 8988 ","tty":"","tollFree":"","fax":"","email":"hello@cgdsociety.org","url":"https://cgdsociety.org/","freeText":""},{"resourceID":4018,"resourceName":"Primary Immune Deficiency UK","abbreviation":"PID UK","address1":"PO Box 6970","address2":"","address3":"","address4":"","address5":"","city":"Basingstoke","state":"","zip":"RG24 4XL","country":"United Kingdom","phone":"","tty":"","tollFree":"0800 987 8986","fax":"","email":"hello@piduk.org","url":"http://www.piduk.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=chronic%5BTitle%5D%20AND%20granulomatous%5BTitle%5D%20AND%20disease%5BTitle%5D%20AND%20%28hasabstract%5Btext%5D%20AND%20%22loattrfree%20full%20text%22%5Bsb%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Chronic granulomatous disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Chronic+granulomatous+disease%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Chronic granulomatous disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://medlineplus.gov/genetics/condition/chronic-granulomatous-disease/' target='_blank'>MedlinePlus Genetics</a> contains information on Chronic granulomatous disease. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":877,"resourceId":1583,"resourceName":"RDCRN - Primary Immune Deficiency Treatment Consortium (PIDTC)","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/cms/pidtc/' target='_blank'>Primary Immune Deficiency Treatment Consortium (PIDTC)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with&nbsp;severe combined immunodeficiency, Wiskott-Aldrich syndrome, and chronic granulomatous disease&nbsp;through research. The&nbsp;Primary Immune Deficiency Treatment Consortium (PIDTC) has a registry for patients who wish to be contacted about clinical research opportunities.","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0018203/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/682/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001239.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1116022-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=379' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/sec16/ch184/ch184c.html#sec16-ch184-ch184l-136' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1559,"resourceId":2185,"resourceName":"National Institute of Allergy and Infectious Diseases","descriptionText":"The <a href='http://www.niaid.nih.gov/topics/immuneDeficiency/Understanding/Pages/cgd.aspx' target='_blank'>National Institute of Allergy and Infectious Diseases</a> (NIAID) supports scientists developing better ways to diagnose, treat, and prevent the many infectious, immunologic, and allergic diseases that afflict people worldwide.  Click on the link to view information on&nbsp;this topic.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/immunology_allergic_disorders/immunodeficiency_disorders/chronic_granulomatous_disease.html' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Chronic granulomatous disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1775,"resourceId":2936,"resourceName":"CGD Society","descriptionText":"The <a href='http://www.cgdsociety.org/whatiscgd' target='_blank'>CGD Society</a> has an information page on Chronic granulomatous disease. Please click the link to access this resource.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2021,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://omim.org/phenotypicSeries/PS306400' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> lists the subtypes and associated genes for Chronic granulomatous disease in a table called Phenotypic Series. Each entry in OMIM includes a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:3265' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2163,"resourceId":3372,"resourceName":"Good Days","descriptionText":"<a href='https://www.mygooddays.org/patients/diseases-covered/chronic-iron-overload' target='_blank'>Good Days</a> provides help to patients with life-altering conditions. Assistance includes help with the cost of medications and travel.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Chronic granulomatous disease. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Chronic granulomatous disease:<br />\r\n<a href='http://esid.org/Working-Parties/Registry' target='_blank'>European Society for Immunodeficiencies (ESID) Registry</a><br /><a href='https://usidnet.org/about-the-registry/patient-participation/' target='_blank'>United States Immunodeficiency Network (USIDENT) Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":4491,"questionText":"What is chronic granulomatous disease?","answerText":"<strong>Chronic granulomatous disease (CGD)</strong> is a rare, inherited <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000818.htm\" target=\"_blank\">immunodeficiency</a> that affects certain white blood cells. People with this condition have <a href=\"https://www.niaid.nih.gov/research/immune-system-overview\" target=\"_blank\">immune systems</a> that do not function properly, leaving the body vulnerable to <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a>&nbsp;inflammation and frequent <a href=\"http://www.nlm.nih.gov/medlineplus/bacterialinfections.html\" target=\"_blank\">bacterial</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/fungalinfections.html\" target=\"_blank\">fungal</a> infections. The features of this condition usually develop in infancy or early childhood; however, milder forms may be diagnosed in the teen years or even in adulthood.[8247][8248] It is caused by changes (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in any one of five different genes and is usually inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> or&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=\"_blank\">X-linked recessive</a> manner.[8249] Treatment consists of continuous therapy with <a href=\"http://www.nlm.nih.gov/medlineplus/antibiotics.html\" target=\"_blank\">antibiotic</a> and antifungal medications to treat and prevent infections.[8247][8250] The&nbsp;only cure for the disease is an&nbsp;<a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=270732\" target=\"_blank\">allogeneic hematopoietic stem cell transplantation</a> (HSCT).[12614]&nbsp;","dateModified":"2016-11-18T00:00:00"},"basicQuestions":[{"questionId":8274,"questionText":"What are the signs and symptoms of chronic granulomatous disease?","answerText":"In people with chronic granulomatous disease, the <a href=\"http://www.niaid.nih.gov/topics/immuneSystem/Pages/overview.aspx\" target=\"_blank\">immune system</a> does not work properly, which leaves the body vulnerable to certain types of <a href=\"http://www.nlm.nih.gov/medlineplus/bacterialinfections.html\" target=\"_blank\">bacteria</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/fungalinfections.html\" target=\"_blank\">fungi</a>. The features of the condition usually develop in infancy or early childhood; however, milder forms may be diagnosed in the teen years or even in adulthood. The signs and symptoms vary but may include:[8247][8248][8249]\r\n<ul>\r\n    <li>Frequent bacterial and fungal infections</li>\r\n    <li>Granulomas (areas of inflamed tissue), most commonly in the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/9790.htm\" target=\"_blank\">gastrointestinal tract</a> and/or the <a href=\"http://ghr.nlm.nih.gov/glossary=genitourinarysystem\" target=\"_blank\">genitourinary system</a></li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001353.htm\" target=\"_blank\">Abscesses</a> that involve the lungs, liver, spleen, bones, or skin</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003097.htm\" target=\"_blank\">Swollen lymph nodes</a></li>\r\n    <li>Persistent diarrhea</li>\r\n    <li><a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">Chronic</a> runny nose.</li>\r\n</ul>\r\n<ul>\r\n</ul>","dateModified":"2016-11-18T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":8247,"authors":"Nowicki RJ","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2018","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1116022-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8248,"authors":"","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"NORD","date":"2018","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/682/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8249,"authors":"","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"MedlinePlus Genetics","date":"2016","volume":"","pages":"","url":"https://medlineplus.gov/genetics/condition/chronic-granulomatous-disease/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8275,"questionText":"What causes chronic granulomatous disease?","answerText":"Chronic granulomatous disease is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in one of five <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>  (<span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/CYBA\" target=\"_blank\">CYBA</a></em></span>, <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/CYBB\" target=\"_blank\">CYBB</a></em></span>, <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NCF1\" target=\"_blank\">NCF1</a></em></span>, <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NCF2\" target=\"_blank\">NCF2</a></em></span>, or <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NCF4\" target=\"_blank\">NCF4</a></em></span>).&nbsp;Each gene encodes a different part (subunit) of an <a href=\"http://www.genome.gov/Glossary/index.cfm?id=58\" target=\"_blank\">enzyme</a> called NADPH oxidase, which is essential to the <a href=\"http://www.niaid.nih.gov/topics/immuneSystem/Pages/overview.aspx\" target=\"_blank\">immune system</a>. One function of this enzyme is to help make toxic substances that are used to kill bacteria and fungi that invade the body before they can cause infection. It may also play a role in regulating the activity of immune cells that help manage the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000821.htm\" target=\"_blank\">inflammatory response</a>. Mutations in these genes lead to reduced levels of NADPH oxidase and in severe cases, no enzyme is produced. As a result, the immune system can not function properly, leaving the body vulnerable to frequent infections and&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a> inflammation.[8249] <br />\r\n<br />\r\nFor background information on how the body naturally responds to invading bacteria, visit the link about the&nbsp;<a href=\"https://www.niaid.nih.gov/research/immune-system-overview\" target=\"_blank\">immune system</a>&nbsp;offered by the National Institute of Allergy and Infectious Diseases (NIAID). &nbsp;","dateModified":"2016-11-18T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":8249,"authors":"","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"MedlinePlus Genetics","date":"2016","volume":"","pages":"","url":"https://medlineplus.gov/genetics/condition/chronic-granulomatous-disease/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8276,"questionText":"How is chronic granulomatous disease inherited?","answerText":"When chronic granulomatous disease is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/CYBA\" target=\"_blank\"><em>CYBA</em></a>, <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NCF1\" target=\"_blank\">NCF1</a></em></span>, <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NCF2\" target=\"_blank\">NCF2</a></em></span>, or <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NCF4\" target=\"_blank\">NCF4</a></em></span> genes, it is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[12614][8249] This means that a person must have a change in both copies of the disease-causing <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>  in each <a href=\"http://ghr.nlm.nih.gov/handbook/basics/cell\" target=\"_blank\">cell</a>. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as <a href=\"http://www.genome.gov/Glossary/index.cfm?id=23\" target=\"_blank\">carriers</a>. Carriers typically do not show signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% chance to not have the condition <em>and</em> not be a carrier.<br />\r\n<br />\r\n<span>When chronic granulomatous disease is caused by mutations in the <a href=\"https://ghr.nlm.nih.gov/gene/CYBB\"><em>CYBB</em></a> gene, the condition is inherited in an <a href=\"https://ghr.nlm.nih.gov/art/large/xlinkrecessive.jpeg\" title=\"Show picture\">X-linked recessive pattern</a>. The <em>CYBB</em> gene is located on the <a href=\"https://ghr.nlm.nih.gov/chromosome/X\">X chromosome</a>, which is one of the two sex chromosomes. In males (who have only one X chromosome), one mutated copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two mutated copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons. Rarely, females with one mutated copy of the <em>CYBB</em> gene have mild symptoms of chronic granulomatous disease, such as an increased frequency of bacterial or fungal infections.[8249]</span>","dateModified":"2016-11-18T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":8249,"authors":"","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"MedlinePlus Genetics","date":"2016","volume":"","pages":"","url":"https://medlineplus.gov/genetics/condition/chronic-granulomatous-disease/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12614,"authors":"Leiding JW & Holland SM","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"GeneReviews","date":"February 11, 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK99496/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8277,"questionText":"How is chronic granulomatous disease diagnosed?","answerText":"A diagnosis of chronic granulomatous disease is often suspected based on the presence of characteristic signs and symptoms. Specialized blood tests, such as the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003355.htm\" target=\"_blank\">nitroblue tetrazolium test</a> and/or flow cytometry with dihydrorhodamine, can then be ordered to confirm the diagnosis. Both of these tests can be used to determine whether or not the immune cells are making toxic substances that the body uses to fight infections.[8247][8248]<br />\r\n<br />\r\nThe diagnosis of CGD is established with identification of the mutation(s) in one of five <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>:[12468]<br />\r\n<ul>\r\n    <li><em>CYBA, NCF1, NCF2</em>, and <em>NCF4</em> (the genes related to <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>  chronic granulomatous disease)&nbsp;</li>\r\n    <li><em>CYBB</em> is the gene related to the <a href=\"http://www.genome.gov/Glossary/index.cfm?id=209\" target=\"_blank\">X-linked</a>  chronic granulomatous disease.</li>\r\n</ul>","dateModified":"2016-11-18T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":8247,"authors":"Nowicki RJ","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2018","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1116022-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8248,"authors":"","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"NORD","date":"2018","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/682/viewAbstract","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":5366,"questionText":"How might chronic granulomatous disease be treated?","answerText":"Chronic granulomatous disease is usually managed with <a href=\"http://www.nlm.nih.gov/medlineplus/antibiotics.html\" target=\"_blank\">antibiotic</a>  and antifungal medications to treat and prevent infection. <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">Corticosteriods</a> may be used to shrink granulomas (areas of inflamed tissue). Treatment may also include a medication called Actimmune (also known as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601152.html\" target=\"_blank\">interferon gamma-1b</a>). Actimmune is a man-made version of a substance normally produced by the body's immune cells and has been shown to decrease the frequency of severe infections in people with chronic granulomatous disease.[8247][8248][8250][12614][12807]&nbsp;<br />\r\n<br />\r\nEarly diagnosis of infection is very important, so people with chronic granulomatous disease are generally followed closely by a medical professional. The frequency of follow-up will depend on the severity of the condition.[8247][8248][8250]<br />\r\n<br />\r\nA&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm\" target=\"_blank\">bone marrow transplant</a>&nbsp;(<a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=270732\" target=\"_blank\">allogeneic hematopoietic stem cell transplantation</a> or HSCT) may be used to treat and possibly cure chronic granulomatous disease, however HSCT has serious risks including the possibility of severe disability or death. Although the risks associated with HSCT are decreasing due to medical advances, HSCT is usually only considered for those severely affected by chronic granulomatous disease.[8247][8248][8250][12614]<br />\r\n<br />\r\nMedical researchers believe gene therapy also holds great promise as a future cure, but more clinical studies are needed to determine if gene therapy will be both safe and effective for those with chronic granulomatous disease.[8250][12614] As medical researchers better understand  chronic granulomatous disease, new treatments that help control the immune system (immunomodulatory agents) may also become available.[12807]","dateModified":"2016-12-19T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":8247,"authors":"Nowicki RJ","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2018","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1116022-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8248,"authors":"","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"NORD","date":"2018","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/682/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8250,"authors":"Rosenzweig SD & Holland SM","articleTitle":"Chronic granulomatous disease: Treatment and prognosis","bookWebsiteJournalTitle":"UpToDate","date":"2018","volume":"","pages":"","url":"http://www.uptodate.com/contents/chronic-granulomatous-disease-treatment-and-prognosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12614,"authors":"Leiding JW & Holland SM","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"GeneReviews","date":"February 11, 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK99496/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12807,"authors":"Vignesh P, Rawat A & Singh S","articleTitle":"An Update on the Use of Immunomodulators in Primary Immunodeficiencies","bookWebsiteJournalTitle":"Clin Rev Allergy Immunol.","date":"Nov 21 2016","volume":"[Epub ahead of print]","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/27873163","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8280,"questionText":"What is the long-term outlook for people with chronic granulomatous disease?","answerText":"The long-term outlook (prognosis) for people with chronic granulomatous disease varies depending on the severity of their condition. Frequent infections and episodes of inflammation can reduce the life expectancy of people with the condition. However, recent advances in therapy have drastically improved the survival and quality of life.[8247][8250] In fact, the average person with chronic granulomatous disease now survives at least 40 years, due in large part to routine use of <a href=\"http://c.merriam-webster.com/medlineplus/prophylactic\" target=\"_blank\">prophylactic</a> therapies.[8250]","dateModified":"2016-11-18T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":8247,"authors":"Nowicki RJ","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2018","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1116022-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8250,"authors":"Rosenzweig SD & Holland SM","articleTitle":"Chronic granulomatous disease: Treatment and prognosis","bookWebsiteJournalTitle":"UpToDate","date":"2018","volume":"","pages":"","url":"http://www.uptodate.com/contents/chronic-granulomatous-disease-treatment-and-prognosis","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":32314,"abbreviatedInquiry":"The information I have read said that most infections occur in younger people. I have not had any major problems until now at 56 years of age. Should I be under a doctors care regularly? Am I a candidate for disability?","caseQuestions":[{"questionId":5365,"questionText":"Is it uncommon for symptoms of chronic granulomatous disease to begin in adulthood?","answerText":"Signs and symptoms of chronic granulomatous disease usually present in childhood, often before the age of five. However, a growing number of people with this condition are being diagnosed in later childhood or adulthood. This may be due in part to better detection of milder cases.[8252]","dateModified":"2015-02-11T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":8252,"authors":"Sergio D Rosenzweig, MD; Steven M Holland, MD","articleTitle":"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"2018","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":5366,"questionText":"How might chronic granulomatous disease be treated?","answerText":"Chronic granulomatous disease is usually managed with <a href=\"http://www.nlm.nih.gov/medlineplus/antibiotics.html\" target=\"_blank\">antibiotic</a>  and antifungal medications to treat and prevent infection. <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">Corticosteriods</a> may be used to shrink granulomas (areas of inflamed tissue). Treatment may also include a medication called Actimmune (also known as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601152.html\" target=\"_blank\">interferon gamma-1b</a>). Actimmune is a man-made version of a substance normally produced by the body's immune cells and has been shown to decrease the frequency of severe infections in people with chronic granulomatous disease.[8247][8248][8250][12614][12807]&nbsp;<br />\r\n<br />\r\nEarly diagnosis of infection is very important, so people with chronic granulomatous disease are generally followed closely by a medical professional. The frequency of follow-up will depend on the severity of the condition.[8247][8248][8250]<br />\r\n<br />\r\nA&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm\" target=\"_blank\">bone marrow transplant</a>&nbsp;(<a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=270732\" target=\"_blank\">allogeneic hematopoietic stem cell transplantation</a> or HSCT) may be used to treat and possibly cure chronic granulomatous disease, however HSCT has serious risks including the possibility of severe disability or death. Although the risks associated with HSCT are decreasing due to medical advances, HSCT is usually only considered for those severely affected by chronic granulomatous disease.[8247][8248][8250][12614]<br />\r\n<br />\r\nMedical researchers believe gene therapy also holds great promise as a future cure, but more clinical studies are needed to determine if gene therapy will be both safe and effective for those with chronic granulomatous disease.[8250][12614] As medical researchers better understand  chronic granulomatous disease, new treatments that help control the immune system (immunomodulatory agents) may also become available.[12807]","dateModified":"2016-12-19T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":8247,"authors":"Nowicki RJ","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2018","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1116022-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8248,"authors":"","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"NORD","date":"2018","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/682/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8250,"authors":"Rosenzweig SD & Holland SM","articleTitle":"Chronic granulomatous disease: Treatment and prognosis","bookWebsiteJournalTitle":"UpToDate","date":"2018","volume":"","pages":"","url":"http://www.uptodate.com/contents/chronic-granulomatous-disease-treatment-and-prognosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12614,"authors":"Leiding JW & Holland SM","articleTitle":"Chronic Granulomatous Disease","bookWebsiteJournalTitle":"GeneReviews","date":"February 11, 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK99496/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12807,"authors":"Vignesh P, Rawat A & Singh S","articleTitle":"An Update on the Use of Immunomodulators in Primary Immunodeficiencies","bookWebsiteJournalTitle":"Clin Rev Allergy Immunol.","date":"Nov 21 2016","volume":"[Epub ahead of print]","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/27873163","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":5367,"questionText":"Are people with chronic granulomatous disease eligible for disability?","answerText":"Eligibility for disability depends not on diagnosis, but degree of condition involvement and impairment. For further information regarding your eligibility, you may find it helpful to speak with a social worker at your local hospital. In addition, you may benefit from visiting <a href=\"https://www.disability.gov/\" target=\"_blank\">Disability.gov</a>, which provides quick and easy access to comprehensive information about disability programs, services, laws and benefits.","dateModified":"2015-02-11T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15513,"phenoTypeName":"Abnormality of neutrophils","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10169,"phenoTypeName":"Chronic pulmonary obstruction","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8275,"phenoTypeName":"Cutaneous photosensitivity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8313,"phenoTypeName":"Hypermelanotic macule","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13413,"phenoTypeName":"Malabsorption","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11806,"phenoTypeName":"Mediastinal lymphadenopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11325,"phenoTypeName":"Otitis media","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13411,"phenoTypeName":"Pyloric stenosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9832,"phenoTypeName":"Sinusitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13755,"phenoTypeName":"Tracheoesophageal fistula","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10289,"phenoTypeName":"Eczema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9812,"phenoTypeName":"Gingivitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11715,"phenoTypeName":"Inflammatory abnormality of the eye","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11705,"phenoTypeName":"Liver abscess","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8738,"phenoTypeName":"Meningitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1873,"phenoTypeName":"Sepsis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":967,"phenoTypeName":"Skin ulcer","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":512,"genericName":"Interferon gamma-1b","tradeName":"Actimmune®","tradeLink":"http://www.actimmune.com/","manufacturer":"","sponsor":"InterMune , Inc.","indication":"Treatment of chronic granulomatous disease.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Actimmune","medlinePlusLink":""}],"EncodedName":"Chronic_granulomatous_disease"}